Yüklüyor......

Update on JAK2 Inhibitors in Myeloproliferative Neoplasm

Since the discovery of mutant Janus Kinase 2 (JAK2), JAK2 V617F, in a major proportion of myeloproliferative neoplasm (MPN) patients, there has been a flurry of activity in the development of JAK2 inhibitors. Pan-JAK, predominantly JAK2 and off-target JAK2 inhibitors have been developed in the short...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chan, Daniel, Koren-Michowitz, Maya
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2011
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3573400/
https://ncbi.nlm.nih.gov/pubmed/23556077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620711401646
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!